Clinical trial
A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease
NCT07059871 is registered in ClinicalTrials.gov with Zhejiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease
- Lead sponsor
- Zhejiang Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 23, 2025
- Completion date
- December 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ad - alzheimer's disease, asthenia, sarcopenia